Market seems to have missed the fact that Eli Lillys Donanemab was cleared by the FDA the other night (unanimously). Good news for CGS (of course assuming it receives full FDA approval).
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-review-eli-lilly-alzheimers-drug-2024-06-10/
- Forums
- ASX - By Stock
- CGS
- Eli Lilly
Eli Lilly
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
-0.040(3.54%) |
Mkt cap ! $186.1M |
Open | High | Low | Value | Volume |
$1.09 | $1.09 | $1.06 | $141.5K | 131.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 23099 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 5109 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 23099 | 1.090 |
1 | 17806 | 1.085 |
1 | 5000 | 1.050 |
2 | 2800 | 1.000 |
1 | 1400 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
1.100 | 5109 | 2 |
1.130 | 1020 | 2 |
1.140 | 30369 | 2 |
1.200 | 12900 | 1 |
1.230 | 23012 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |